Skip to main content
. 2019 Jun 6;34(4):153–160. doi: 10.1097/YIC.0000000000000271

Fig. 2.

Fig. 2

Efficacy assessments across study period (FAS, MMRM). IV vortioxetine + oral vortioxetine, n = 27; IV placebo + oral vortioxetine, n = 28. Treatment differences are based on the least squares means; error bars represent standard errors. CGI-I, Clinical Global Impressions-Improvement; CGI-S, Clinical Global Impressions-Severity of Illness; FAS, full-analysis set; HADS-A, Hospital Anxiety and Depression Scale-Anxiety; HADS-D, Hospital Anxiety and Depression Scale-Depression; IV, intravenous; MADRS, Montgomery Åsberg Depression Scale; MMRM, mixed model for repeated measurements.